Document is current
Any future updates will be listed below
-
Authors
Stalder, P.
Serdiuk, T. https://orcid.org/0000-0002-3706-5911
Ghosh, D. https://orcid.org/0000-0003-2087-8075
Fleischmann, Y.
Ait-Bouziad, N.
Quast, J.-P.
Malinovska, L.
Ouared, A.
Davranche, A.
Haenseler, W. https://orcid.org/0000-0003-4868-3704
Boudou, C. https://orcid.org/0000-0001-7230-2380
Tsika, E.
Stöhr, J.
Melki, R.
Riek, R.
de Souza, N.
Picotti, P. https://orcid.org/0000-0002-4109-3552
- License Information
-
More Information
Article History
Received: 6 November 2023
Accepted: 14 April 2025
First Online: 10 May 2025
Competing interests
: AC Immune (ACI) provided two of the compounds used in the study and Ait-Bouziad, N., Davranche, A., Boudou, C., Tsika, E., Ouared, A., and Stöhr, J. are employees of ACI. LiP-MS is subject of a patent licensed to the company Biognosys. The other authors declare no competing interests.
